NDC 50090-4622-01 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-4622
- Requested NDC
- 50090-4622-01
- Package NDCs from labels
- 50090-4622-0, 50090-4622-1, 50090-4622-3, 50090-4622-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-06-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - A-S Medication Solutions | A-S Medication Solutions | 2024-06-03 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-4622-0 | 2023-02-06 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-1 | 2023-02-06 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-3 | 2023-02-06 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-0 | 2023-01-30 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-1 | 2023-01-30 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
| 50090-4622-3 | 2023-01-30 | OXYBUTYNIN CHLORIDE TABLETS, USP Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4622-0 | Oxybutynin Chloride | 30 in 1 BOTTLE | TABLET | 30 | 11 | |
| 50090-4622-1 | Oxybutynin Chloride | 100 in 1 BOTTLE | TABLET | 100 | 11 | |
| 50090-4622-3 | Oxybutynin Chloride | 90 in 1 BOTTLE | TABLET | 90 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4622 | OXYBUTYNIN CHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 3 package rows | 20240604_39a2d144-0c10-4aec-9fa4-0adc24b332eb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4622-0 | EA - Each | 50090-4622 | 341581ec-a389-4c39-8913-c2b1c57eb2e7 | 1 | 2022-12-07 |
| 50090-4622-1 | EA - Each | 50090-4622 | 79095bee-3fb1-4c38-be46-3f6c2720332e | 1 | 2022-12-07 |
| 50090-4622-3 | EA - Each | 50090-4622 | f9e87985-b8f4-4b6d-9ca1-73269e326b73 | 1 | 2022-12-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0c021aad-97a3-4404-a11e-cdd2ec731c6b | 2025-03-07 | Warnings, Adverse reactions | ANDA209335 863664 L9F3D9RENQ |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3a319017-4e25-402e-8ba0-63b9f1eb707e | 2025-02-27 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Chartwell RX, LLC | d02e411b-2f34-4d08-a92a-9762cab47269 | 2025-02-26 | Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | f92cf6d0-5f49-40e2-a4f4-8ff377cacbfb | 2025-01-30 | Warnings, Adverse reactions | ANDA209335 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Redpharm Drug | fc4cfbe6-a940-41c0-e053-6294a90adb14 | 2025-01-23 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | direct rx | b3d6d2a8-97c4-5bad-e053-2a95a90a155d | 2025-01-17 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | DIRECT RX | ada3be87-2cdd-75f7-e053-2995a90aa95b | 2025-01-17 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Golden State Medical Supply, Inc. | 6f409d7f-b064-1363-e053-2a91aa0a3a14 | 2024-12-23 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | KVK-Tech, Inc. | f99fdfe8-a980-4a72-bc99-aa2ce0bdfd86 | 2024-12-06 | Warnings, Adverse reactions | ANDA209335 10702-201 863664 289ec3ce-2fb1-608b-e063-6394a90a4a7a f99fdfe8-a980-4a72-bc99-aa2ce0bdfd86 L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | Zydus Lifesciences Limited | f405a774-bd91-4513-b7c7-c44f0596d988 | 2024-12-03 | L9F3D9RENQ | |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | ANI Pharmaceuticals, Inc. | 3b1f5585-9b33-4a96-bf33-8e6bab14bf0c | 2024-11-25 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 2425f49f-ade3-5178-e063-6294a90adfac | 2024-10-10 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 246d2f79-8ab5-4023-9068-1451b695ac16 | 2024-10-03 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | NCS HealthCare of KY, LLC dba Vangard Labs | ec4fd95f-16dc-4acf-b560-b67b7aaef08b | 2024-09-13 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Teva Pharmaceuticals USA, Inc. | cb7aba8d-6913-4f57-8eb4-c6d6ff0b2a29 | 2024-09-02 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | NuCare Pharmaceuticals,Inc. | 8e830697-a6d3-13ed-e053-2995a90acb11 | 2024-08-14 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | NCS HealthCare of KY, LLC dba Vangard Labs | ed10f0c9-23d6-4ded-b17f-ed474632a965 | 2024-08-12 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | f26e590d-956e-493b-a6ac-6056aeeaf411 | 2024-08-09 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | f8ed80f2-6c3d-4d7f-b761-c2447973c1f9 | 2024-07-03 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.